Inogen | INGN - Ativo Circulante





Ativo Circulante Alterar Data
Abbott USD 23.5B 1.02B 2026-09
Accuray USD 292.39M 11.22M 2025-12
AngioDynamics USD 161.35M 4.69M 2025-09
Artivion USD 371.38M 13.86M 2026-06
AtriCure USD 363.39M 17.86M 2026-09
Baxter International USD 6.83B 163M 2026-09
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Boston Scientific USD 8.16B 192M 2026-09
Cooper Companies USD 2.28B 18.3M 2026-06
Dexcom USD 3.92B 170.6M 2026-09
Edwards Lifesciences USD 7.25B 428.6M 2026-09
Globus Medical USD 2.22B 17.39M 2026-06
Inogen USD 203.72M 594K 2025-09
Insulet USD 2.04B 192.4M 2026-09
Medtronic USD 24.39B 397M 2026-06
Orthofix International USD 446.13M 15.39M 2026-06
Philips EUR 9.33B 454M 2026-06
ResMed USD 3.51B 815.82M 2026-09
Steris USD 2.48B 33.4M 2026-09
Stryker USD 14.18B 235M 2026-09
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teleflex USD 1.84B 31.2M 2026-09
X T L Biopharmaceuticals USD 166K 367K 2025-12
Zimmer Biomet Holdings USD 5.13B 32.3M 2026-09